BIRC5 and diffuse large B-cell lymphoma: In short, we demonstrate that SM1044 treatment affects DLBCL cell survival both in vitro and in vivo, through the induction of autophagy as well as an autophagy‐dependent degradation of Survivin, followed by caspase‐dependent apoptosis.